Lauren A. White
Chief Financial OfficerMs. Lauren A. White, M.B.A., is Chief Financial Officer at Seaport Therapeutics from November 2024. She is the Chief Financial Officer at PureTech Health plc since November 2024. She served as Senior Vice President and Chief Financial Officer at ImmunoGen, Inc. since September 18, 2023 until 2024. She served as the Chief Financial Officer at C4 Therapeutics, Inc. since June 21, 2021 and served as its Treasurer. She served as vice president and global head of business planning and analysis at Novartis Institutes for BioMedical Research (NIBR), where she led strategic financial projects for the global research unit. Ms. White also launched the global health business unit as chief financial officer after serving in roles across global finance and financial reporting and accounting. She has experience in corporate finance and strategy. Ms. White worked in strategy and marketing roles with Boston Consulting Group and General Electric. Ms. White earned an M.B.A. from Harvard Business School and a B.S. from the Carroll School of Management at Boston College.
公司职务
- 公司名称PureTech Health plc股票代码PRTCY职务Chief Financial Officer
- 公司名称Seaport Therapeutics, Inc.股票代码SPTX职务Chief Financial Officer共事同僚
- SMSteven M. PaulFounder & Non-Employee Chair of the Board
- DZDaphne ZoharFounder, CEO, President & Director
- MCMichael Cunyuan ChenCo-Founder & Chief Scientific Officer
- ALAntony LoebelChief Medical Officer & President of Clinical Development
- LALauren A. WhiteChief Financial Officer
- DMDenice M. TorresLead Independent Non-Employee Director
- SESandra E. PetersonIndependent Non-Employee Director
- RJRobert J. HombachIndependent Non-Employee Director
